FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087050596> ?p ?o ?g. }

• W3087050596 endingPage "e1398" @default.
• W3087050596 startingPage "e1390" @default.
• W3087050596 abstract "BackgroundPopulation-based data on COVID-19 are essential for guiding policies. There are few such studies, particularly from low or middle-income countries. Brazil is currently a hotspot for COVID-19 globally. We aimed to investigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence by city and according to sex, age, ethnicity group, and socioeconomic status, and compare seroprevalence estimates with official statistics on deaths and cases.MethodsIn this repeated cross-sectional study, we did two seroprevalence surveys in 133 sentinel cities in all Brazilian states. We randomly selected households and randomly selected one individual from all household members. We excluded children younger than 1 year. Presence of antibodies against SARS-CoV-2 was assessed using a lateral flow point-of-care test, the WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech, Guangzhou, China), using two drops of blood from finger prick samples. This lateral-flow assay detects IgG and IgM isotypes that are specific to the SARS-CoV-2 receptor binding domain of the spike protein. Participants also answered short questionnaires on sociodemographic information (sex, age, education, ethnicity, household size, and household assets) and compliance with physical distancing measures.FindingsWe included 25 025 participants in the first survey (May 14–21) and 31 165 in the second (June 4–7). For the 83 (62%) cities with sample sizes of more than 200 participants in both surveys, the pooled seroprevalence increased from 1·9% (95% CI 1·7–2·1) to 3·1% (2·8–3·4). City-level prevalence ranged from 0% to 25·4% in both surveys. 11 (69%) of 16 cities with prevalence above 2·0% in the first survey were located in a stretch along a 2000 km of the Amazon river in the northern region. In the second survey, we found 34 cities with prevalence above 2·0%, which included the same 11 Amazon cities plus 14 from the northeast region, where prevalence was increasing rapidly. Prevalence levels were lower in the south and centre-west, and intermediate in the southeast, where the highest level was found in Rio de Janeiro (7·5% [4·2–12·2]). In the second survey, prevalence was similar in men and women, but an increased prevalence was observed in participants aged 20–59 years and those living in crowded conditions (4·4% [3·5–5·6] for those living with households with six or more people). Prevalence among Indigenous people was 6·4% (4·1–9·4) compared with 1·4% (1·2–1·7) among White people. Prevalence in the poorest socioeconomic quintile was 3·7% (3·2–4·3) compared with 1·7% (1·4–2·2) in the wealthiest quintile.InterpretationAntibody prevalence was highly heterogeneous by country region, with rapid initial escalation in Brazil's north and northeast. Prevalence is strongly associated with Indigenous ancestry and low socioeconomic status. These population subgroups are unlikely to be protected if the policy response to the pandemic by the national government continues to downplay scientific evidence.FundingBrazilian Ministry of Health, Instituto Serrapilheira, Brazilian Collective Health Association, and the JBS Fazer o Bem Faz Bem." @default.
• W3087050596 created "2020-09-25" @default.
• W3087050596 creator A5000148954 @default.
• W3087050596 creator A5000727171 @default.
• W3087050596 creator A5016183751 @default.
• W3087050596 creator A5019752839 @default.
• W3087050596 creator A5029740688 @default.
• W3087050596 creator A5039445190 @default.
• W3087050596 creator A5042367207 @default.
• W3087050596 creator A5043102833 @default.
• W3087050596 creator A5061355571 @default.
• W3087050596 creator A5080098071 @default.
• W3087050596 creator A5081699517 @default.
• W3087050596 creator A5087114182 @default.
• W3087050596 creator A5091612754 @default.
• W3087050596 date "2020-11-01" @default.
• W3087050596 modified "2023-10-12" @default.
• W3087050596 title "SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys" @default.
• W3087050596 cites W1918432791 @default.
• W3087050596 cites W1972009144 @default.
• W3087050596 cites W2139168999 @default.
• W3087050596 cites W2168195699 @default.
• W3087050596 cites W3015281372 @default.
• W3087050596 cites W3017576620 @default.
• W3087050596 cites W3020041202 @default.
• W3087050596 cites W3024178701 @default.
• W3087050596 cites W3034680516 @default.
• W3087050596 cites W3036931136 @default.
• W3087050596 cites W3038328918 @default.
• W3087050596 cites W3041573255 @default.
• W3087050596 doi "https://doi.org/10.1016/s2214-109x(20)30387-9" @default.
• W3087050596 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7511212" @default.
• W3087050596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32979314" @default.
• W3087050596 hasPublicationYear "2020" @default.
• W3087050596 type Work @default.
• W3087050596 sameAs 3087050596 @default.
• W3087050596 citedByCount "278" @default.
• W3087050596 countsByYear W30870505962020 @default.
• W3087050596 countsByYear W30870505962021 @default.
• W3087050596 countsByYear W30870505962022 @default.
• W3087050596 countsByYear W30870505962023 @default.
• W3087050596 crossrefType "journal-article" @default.
• W3087050596 hasAuthorship W3087050596A5000148954 @default.
• W3087050596 hasAuthorship W3087050596A5000727171 @default.
• W3087050596 hasAuthorship W3087050596A5016183751 @default.
• W3087050596 hasAuthorship W3087050596A5019752839 @default.
• W3087050596 hasAuthorship W3087050596A5029740688 @default.
• W3087050596 hasAuthorship W3087050596A5039445190 @default.
• W3087050596 hasAuthorship W3087050596A5042367207 @default.
• W3087050596 hasAuthorship W3087050596A5043102833 @default.
• W3087050596 hasAuthorship W3087050596A5061355571 @default.
• W3087050596 hasAuthorship W3087050596A5080098071 @default.
• W3087050596 hasAuthorship W3087050596A5081699517 @default.
• W3087050596 hasAuthorship W3087050596A5087114182 @default.
• W3087050596 hasAuthorship W3087050596A5091612754 @default.
• W3087050596 hasBestOaLocation W30870505961 @default.
• W3087050596 hasConcept C126322002 @default.
• W3087050596 hasConcept C137403100 @default.
• W3087050596 hasConcept C138816342 @default.
• W3087050596 hasConcept C142052008 @default.
• W3087050596 hasConcept C142724271 @default.
• W3087050596 hasConcept C144024400 @default.
• W3087050596 hasConcept C147077947 @default.
• W3087050596 hasConcept C149923435 @default.
• W3087050596 hasConcept C159110408 @default.
• W3087050596 hasConcept C159654299 @default.
• W3087050596 hasConcept C19165224 @default.
• W3087050596 hasConcept C203014093 @default.
• W3087050596 hasConcept C2778494684 @default.
• W3087050596 hasConcept C2779134260 @default.
• W3087050596 hasConcept C2908647359 @default.
• W3087050596 hasConcept C3008058167 @default.
• W3087050596 hasConcept C45189115 @default.
• W3087050596 hasConcept C524204448 @default.
• W3087050596 hasConcept C71924100 @default.
• W3087050596 hasConcept C89623803 @default.
• W3087050596 hasConcept C99454951 @default.
• W3087050596 hasConceptScore W3087050596C126322002 @default.
• W3087050596 hasConceptScore W3087050596C137403100 @default.
• W3087050596 hasConceptScore W3087050596C138816342 @default.
• W3087050596 hasConceptScore W3087050596C142052008 @default.
• W3087050596 hasConceptScore W3087050596C142724271 @default.
• W3087050596 hasConceptScore W3087050596C144024400 @default.
• W3087050596 hasConceptScore W3087050596C147077947 @default.
• W3087050596 hasConceptScore W3087050596C149923435 @default.
• W3087050596 hasConceptScore W3087050596C159110408 @default.
• W3087050596 hasConceptScore W3087050596C159654299 @default.
• W3087050596 hasConceptScore W3087050596C19165224 @default.
• W3087050596 hasConceptScore W3087050596C203014093 @default.
• W3087050596 hasConceptScore W3087050596C2778494684 @default.
• W3087050596 hasConceptScore W3087050596C2779134260 @default.
• W3087050596 hasConceptScore W3087050596C2908647359 @default.
• W3087050596 hasConceptScore W3087050596C3008058167 @default.
• W3087050596 hasConceptScore W3087050596C45189115 @default.
• W3087050596 hasConceptScore W3087050596C524204448 @default.
• W3087050596 hasConceptScore W3087050596C71924100 @default.
• W3087050596 hasConceptScore W3087050596C89623803 @default.
• W3087050596 hasConceptScore W3087050596C99454951 @default.

• next